The cumulative returns show that the top 200 Nasdaq stocks all grow uniformly in the initial period of the rebound till May ...

The Invesco QQQ ETF ($QQQ), which tracks the performance of the Nasdaq 100 Index (NDX), was down 0.47% in Monday’s pre-market ...

This ETF brings geographic diversification to portfolios with an above-average (though not risky) dividend yield.

Amazon stock is lagging the market in 2025, but ETFs haven't rotated away. Over 200 funds still hold AMZN, leaving investors ...

This ETF is a “training ground” of sorts for a pair of popular funds. It's a sound idea for investors who want to diversify away from mega-cap stocks while maintaining growth exposure. This fund could ...

The technology sector gets a lot of love from financial media, retail investors and sell-side firms. It’s home to the biggest players in the ongoing AI rally, as well as most of the Magnificent Seven ...

One of the bigger investing myths is that it's complicated and time-consuming. This couldn't be further from the truth, especially when you're investing in exchange-traded funds (ETFs). ETFs allow you ...

After gaining more than 20% in 2023 and again in 2024, the S&P 500 (SNPINDEX: ^GSPC) is up 12.3% year to date at the time of this writing. That means it could close out the final three months of the ...

Amid the trying circumstances in the market right now, investors may be well served to target the best biotech ETFs to buy. Fundamentally, these exchange-traded funds benefit from permanent relevance.

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, they give sector participants exposure to many biotech companies via one ...

Danielle Rutsky, Lead Product Manager of ETF Listings at Nasdaq, joins Frank Spiteri, Head of Asset Management at CoinShares, for a conversation about CoinShares’s outlook on crypto in the US Markets.